CFMS News and Press, Conformis Inc. From 12/23/21

BILLERICA, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate Secretary, has notified the Company that he will be departing the Company on January 16, 2022 to become the General Counsel at Bruke...

Kezar Life Sciences (NASDAQ:KZR) +46% on phase 2 data for lupus candidate Axon Enterprise (NASDAQ:AXON) +24% on Q3 results Cyclo Therapeutics (NASDAQ:CYTH) +19% on Q3 results. Comstock Holding Companies (NASDAQ:CHCI) +20% on Q3 results. Romeo Power (NYS...

BILLERICA, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new Vice President, U.S. Marketing. “Conformis is pleased to welcome James Paiva as the new V.P. of U.S. ...

Conformis, Inc. (CFMS) Q3 2021 Earnings Conference Call November 03, 2021, 04:30 PM ET Company Participants Mark Augusti - President, Chief Executive Officer Bob Howe - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen. Stephen Litman - Oppenheimer & Co. Presentat...

ConforMIS (NASDAQ:CFMS): GAAP EPS of -$0.07 misses by $0.01. Revenue of $14.3M misses by $0.31M. Cash and cash equivalents totaled $97.1 million as of September 30, 2021, compared to $28.7 million as of December 31, 2020. Press Release For further details see: ConforMIS EPS mi...

BILLERICA, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2021. Third Quarter ...

ARK's printing ETF offers exposure to the 3D printing industry while diversifying individual risk to investors. The ETF successfully rotates along the most promising companies engaging in the 3D printing industry. While the ETF is trading below all-time highs reached earlier this ...

BILLERICA, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November 3, 2021 at approximately 4:00 p.m. Eastern Time. Mark August...

BILLERICA, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today the strong results of a published retrospective study of procedures using Conformis’ patient-specific iTotal ® CR (cruciate-retaining) knee replacement implant, which assessed ...

Wednesday was a hump day to forget for specialty medical device maker Conformis (NASDAQ: CFMS) . Investors weren't happy with a guidance cut from the company, and expressed their displeasure by trading its shares down by 10.6%. Conformis, which specializes in products used in hi...